Guild submission on the proposals to widen access to rituximab and zoledronic acid

By

The Guild supported widened access of  Rituximab and Zoledronic acid.  Highlighted the funding and stock keeping constraints.

The Guild supported widened access of  Rituximab and Zoledronic acid.  Highlighted the funding and stock keeping constraints.

If you've forgotten your password enter your email address in the field above and click “Forgot Password” to have it emailed to you. Forgot Password